A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Lactose, Anhydrous | Pharmaceutical Secondary Standard; Certified Reference Material. Group: Sweetener standards. |  |
| Lactose Monohydrate | In the solid state, lactose appears as various isomeric forms, depending on the crystallization and drying conditions, i.e. a lactose monohydrate, b-lactose anhydrous, and a-lactose anhydrous. The stable crystalline forms of lactose are a-lactose monohydrate, b-lactose anhydrous, and stable a-lactose anhydrous. Lactose occurs as white to off-white crystalline particles or powder. Lactose is odorless and slightly sweet-tasting; a-lactose is approximately 20% as sweet as sucrose, while b-lactose is 40% as sweet. Synonyms: CapsuLac; GranuLac; Lactochem; lactosum monohydricum; Monohydrate; Pharmatose; PrismaLac; SacheLac; SorboLac; SpheroLac; SuperTab 30GR; Tablettose. CAS No. 5989-81-1. Product ID: PE-0460. Molecular formula: C12H22O11· H2O. Mole weight: 360.31. Category: Binder Excipients. Product Keywords: Pharmaceutical Excipients; Excipients for Solid Dosage Form; Lactose Monohydrate; Binder Excipients; Binder Excipients; C12H22O11· H2O; 5989-81-1; 5989-81-1. UNII: EWQ57Q8I5X. Chemical Name: O-b-D-Galactopyranosyl-(1→4)-a-D-glucopyranose monohydrate. Grade: Pharmceutical Excipients. Administration route: IM, IV, and SC; oral; inhalation; vaginal. Dosage Form: IM, IV, and SC: powder for injections; oral: capsules and tablets; inhalation preparations; vaginal preparations. Stability and Storage Conditions: Mold growth may occur under humid conditions (80% relative humidity and above). Lactose may develop a brown |  |
| Lactose Monohydrate | It is widely used as a carrier, diluent, and flow aid in dry powder inhalation formulations. Synonyms: Inhalation lactose (lactose monohydrate, cyclic); Alpha-lactose, monohydrate; beta-D-Gal-(1->4)-D-Glc monohydrate; (3R,4R,5S,6R)-6-(hydroxymethyl)-5-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2,3,4-triol hydrate. Grades: 98%. CAS No. 10039-26-6. Molecular formula: C12H24O12. Mole weight: 360.31. |  |
| Lactose Monohydrate | Lactose Monohydrate. CAS No: 64044-51-5 |  Sarchem Laboratories New Jersey NJ |
| Lactose monohydrate (Granulac 200) | 500g Pack Size. Group: Analytical Reagents, Biochemicals, Carbohydrates, Diagnostic Raw Materials. Formula: C12H122O11.H2O. CAS No. 64044-51-5. Prepack ID 90025742-500g. Molecular Weight 360.32. See USA prepack pricing. |  |
| Lactose monohydrate NF | 4-O-b-D-Galactopyranosyl-D-glucose. Grades: NF. CAS No. 64044-51-5. Product ID: 8-01660. Molecular formula: C12H22O11 H2O. Mole weight: 360.31. Source : |  |
| Lactose, Monohydrate, Reagent Grade, 500 g | Formula: C12H24O12 8226; H20. Formula Wt: 360. 31. Storage Code: Green; general chemical storage. Alternative Names: Milk sugar. Grades: chem-grade reagent. CAS No. 5989-81-1. Product ID: 871750. -- SOLD FOR EDUCATIONAL USE ONLY -- |  |
| Lactose N-(Phthalazin-8-yl)-hydrazone | Lactose N-(Phthalazin-8-yl)-hydrazone is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct. Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose. Synonyms: (E)-6-(2-(Phthalazin-1-yl)hydrazono)-3-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,4,5-tetraol. Grades: 95%. Molecular formula: C20H28N4O10. Mole weight: 484.46. | |
| Lactose N-(Phthalazin-8-yl)-hydrazone | Lactose N-(Phthalazin-8-yl)-hydrazone is an intermediate in the synthesis of Hydralazine Lactosone Ring-opened Adduct (H675150). Hydralazine Lactosone Ring-opened Adduct is a derivative of Lactose (L114000). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 500ug, 1mg. Molecular Formula: C20H28N4O10. US Biological Life Sciences. |  Worldwide |
| Lactose octaacetate | Lactose octaacetate, an essential biomedical product, serves as a crucial excipient in drug formulations. Widely embraced in the pharmaceutical realm, it assumes a pivotal role as a tablet and capsule diluent, endowing superior drug stability and promoting efficient drug delivery. Additionally, Lactose octaacetate exhibits its versatility as a pharmaceutical adjuvant, benefiting the treatment of diverse ailments by augmenting drug solubility and optimizing bioavailability. Synonyms: Octa-O-acetyl-D-lactose; 4-O-(2,3,4,6-Tetra-O-acetyl-b-D-galactopyranosyl)-1,2,3,6-tetra-O-acetyl-D-glucopyranose; Peracetylated lactose; Lactose peracetyate. CAS No. 6291-42-5. Molecular formula: C28H38O19. Mole weight: 678.59. | |
| Lactose octaisobutyrate | Lactose octaisobutyrate is a paramount biomedical compound prevalent in the pharmaceutical realm, finding its foremost utilization in drug delivery systems. This multifaceted compound notably studys the solubility and stability of specific compounds, thereby augmenting their bioavailability. Molecular formula: C44H70O19. Mole weight: 903.02. | |
| Lactose oleate | Lactose oleate is a pharmacological compound, exhibiting exceptional promise in diverse medicinal applications. Widely embraced as an indispensable excipient, this compound product unveils its emulsifying prowess in an array of pharmaceutical formulations. CAS No. 85256-00-4. Molecular formula: C18H34O2·C12H22O11. Mole weight: 624.76. | |
| Lactose-PAA-biotin | | |
| Lactose-sp-biotin | Lactose-sp-biotin is a biotin-labeled lactose derivative serving as an affinity probe for studying the carbohydrate-protein interactions involved in lactose metabolism and related pathologies. With its high affinity and specific binding, Lactose-sp-biotin enables the study of lactose-related diseases, like lactose intolerance or galactosemia, contributing to a better understanding of these conditions. Molecular formula: C31H54N4O14S. Mole weight: 738.85. | |
| Lactose (Standard) | Lactose (Standard) is the analytical standard of Lactose. This product is intended for research and analytical applications. Lactose is a β-galactoside consisting of galactose and glucose residues, the main carbohydrate in mammalian breast milk. Lactose, a macronutrient and an inducer of host innate immune responses, possesses immune modulatory functions [1]. Uses: Scientific research. Group: Natural products. CAS No. 63-42-3. Pack Sizes: 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B2123R. |  |
| Lactose Standard 5 % | solid water standard for coulometric/volumetric Karl Fischer Titration and Karl Fischer oven method. Group: Karl fischer reagents and standards. | |
| Lactose standard for IC | 1000 mg/L in water. Group: Anions and cations standards. | |
| lactose synthase | The enzyme is a complex of two proteins, A and B. In the absence of the B protein (α-lactalbumin), the enzyme catalyses the transfer of galactose from UDP-α-D-galactose to N-acetylglucosamine (EC 2.4.1.90 N-acetyllactosamine synthase). Group: Enzymes. Synonyms: UDP-galactose-glucose galactosyltransferase; N-acetyllactosamine synthase; uridine diphosphogalactose-glucose galactosyltransferase; lactose synthetase; UDP-galactose:D-glucose 4-β-D-galactotransferase; UDP-galactose:D-glucose 4-β-D-galactosyltransferase. Enzyme Commission Number: EC 2.4.1.22. CAS No. 9030-11-9. Galactosyltransferase. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2448; lactose synthase; EC 2.4.1.22; 9030-11-9; UDP-galactose-glucose galactosyltransferase; N-acetyllactosamine synthase; uridine diphosphogalactose-glucose galactosyltransferase; lactose synthetase; UDP-galactose:D-glucose 4-β-D-galactotransferase; UDP-galactose:D-glucose 4-β-D-galactosyltransferase. Cat No: EXWM-2448. |  |
| Lactose USP | 4-O-b-D-galactopyranosyl-D-glucose. non-ionic viscosity enhancer for detergent systems. Grades: USP. CAS No. 5989-81-1. Product ID: 3-00171. Molecular formula: C12H22O11. Mole weight: 342.34. Properties: tan solid, hydroxyl value 14-26, saponification value 14-26, iodine value 5-15 pH 4.5-7.5. | |
| Lactosillan | It is produced by the strain of Alcaligenes latus G66A. Latosillan is a cell differentiation inducer that can differentiate myeloid leukemia cells into macrophages. Synonyms: Latosillan. CAS No. 83712-86-1. Molecular formula: C32H55NO23. Mole weight: 821.77. | |
| Lactosyl-b-1,1-N-octanoyl-L-threo-sphingosine | Lactosyl-b-1,1-N-octanoyl-L-threo-sphingosine is a synthetic glycosphingolipid (GSL) with nonnatural stereochemistry. It is a caveolar uptake inhibitor, which blocks SV40 virus infection. Synonyms: C8 L-threo-Lactosyl(β) Ceramide (d18:1/8:0); D-lactosyl-β1-1'-N-octanoyl-L-threo-sphingosine; C8-threo-LacCer. Grades: >99%. CAS No. 939036-94-9. Molecular formula: C38H71NO13. Mole weight: 749.97. | |
| Lactosylceramide | Lactosylceramide, a vital glycosphingolipid molecule, plays an essential role in cell signaling, cell migration, and apoptosis, and is intricately involved in regulating inflammation and immune responses. Synonyms: Ceramide b-lactoside; Ceramide dihexoside (CDH); b-D-Galactosyl-(1-4)-D-glucosylceramide; Lactosyl-N-acylsphingosine; LacCer. CAS No. 4682-48-8. | |
| lactosylceramide 1,3-N-acetyl-β-D-glucosaminyltransferase | This enzyme belongs to the family of glycosyltransferases, specifically the hexosyltransferases. Group: Enzymes. Synonyms: LA2 synthase; β1?3-N-acetylglucosaminyltransferase; uridine diphosphoacetylglucosamine-lactosylceramide β-acetylglucosaminyltransferase; lactosylceramide β-acetylglucosaminyltransferase; UDP-N-acetyl-D-glucosamine:D-galactosyl-1,4-β-D-glucosylceramide β-1,3-acetylglucosaminyltransferase; UDP-N-acetyl-D-glucosamine:β-D-galactosyl-(1?4)-β-D-glucosyl(1<->1)ceramide 3-β-N-acetylglucosaminyltransferase. Enzyme Commission Number: EC 2.4.1.206. CAS No. 83682-80-8. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2433; lactosylceramide 1,3-N-acetyl-β-D-glucosaminyltransferase; EC 2.4.1.206; 83682-80-8; LA2 synthase; β1?3-N-acetylglucosaminyltransferase; uridine diphosphoacetylglucosamine-lactosylceramide β-acetylglucosaminyltransferase; lactosylceramide β-acetylglucosaminyltransferase; UDP-N-acetyl-D-glucosamine:D-galactosyl-1,4-β-D-glucosylceramide β-1,3-acetylglucosaminyltransferase; UDP-N-acetyl-D-glucosamine:β-D-galactosyl-(1?4)-β-D-glucosyl(1<->1)ceramide 3-β-N-acetylglucosaminyltransferase. Cat No: EXWM-2433. | |
| lactosylceramide 4-α-galactosyltransferase | For explanation of superscript II in systematic name, see 2-carb.37. Group: Enzymes. Synonyms: Galβ1-4Glcβ1-Cer α1,4-galactosyltransferase; globotriaosylceramide/CD77 synthase; histo-blood group Pk UDP-galactose; UDP-galactose:lactosylceramide 4II-α-D-galactosyltransferase; UDP-galactose:β-D-galactosyl-(1?4)-D-glucosyl(1<->1)ceramide 4II-α-D-galactosyltransferase; UDP-galactose:β-D-galactosyl-(1?4)-D-glucosyl-(1<->1)-ceramide 4II-α-D-galactosyltransferase. Enzyme Commission Number: EC 2.4.1.228. CAS No. 52725-57-2. Galactosyltransferase. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2457; lactosylceramide 4-α-galactosyltransferase; EC 2.4.1.228; 52725-57-2; Galβ1-4Glcβ1-Cer α1,4-galactosyltransferase; globotriaosylceramide/CD77 synthase; histo-blood group Pk UDP-galactose; UDP-galactose:lactosylceramide 4II-α-D-galactosyltransferase; UDP-galactose:β-D-galactosyl-(1?4)-D-glucosyl(1<->1)ceramide 4II-α-D-galactosyltransferase; UDP-galactose:β-D-galactosyl-(1?4)-D-glucosyl-(1<->1)-ceramide 4II-α-D-galactosyltransferase. Cat No: EXWM-2457. | |
| lactosylceramide α-2,3-sialyltransferase | Lactose cannot act as acceptor. Group: Enzymes. Synonyms: cytidine monophosphoacetylneuraminate-lactosylceramide α2,3- sialyltransferase; CMP-acetylneuraminate-lactosylceramide-sialyltransferase; CMP-acetylneuraminic acid:lactosylceramide sialyltransferase; CMP-sialic acid:lactosylceramide-sialyltransferase; cytidine monophosphoacetylneuraminate-lactosylceramide sialyltransferase; ganglioside GM3 synthetase; GM3 synthase; GM3 synthetase; SAT. Enzyme Commission Number: EC 2.4.99.9. CAS No. 125752-90-1. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2713; lactosylceramide α-2,3-sialyltransferase; EC 2.4.99.9; 125752-90-1; cytidine monophosphoacetylneuraminate-lactosylceramide α2,3- sialyltransferase; CMP-acetylneuraminate-lactosylceramide-sialyltransferase; CMP-acetylneuraminic acid:lactosylceramide sialyltransferase; CMP-sialic acid:lactosylceramide-sialyltransferase; cytidine monophosphoacetylneuraminate-lactosylceramide sialyltransferase; ganglioside GM3 synthetase; GM3 synthase; GM3 synthetase; SAT 1; CMP-N-acetylneuraminate:lactosylceramide α-2,3-N-acetylneuraminyltransferase; CMP-N-acetylneuraminate:β-D-galactosyl-(1?4)-β-D-glucosyl(1<->1)ceramide α-(2?3)-N-acetylneuraminyltransferase. Cat No: EXWM-2713. | |
| lactosylceramide α-2,6-N-sialyltransferase | This enzyme belongs to the family of transferases, specifically those glycosyltransferases that do not transfer hexosyl or pentosyl groups. Group: Enzymes. Synonyms: cytidine monophosphoacetylneuraminate-lactosylceramide sialyltransferase; CMP-acetylneuraminate-lactosylceramide-sialyltransferase; CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase; CMP-sialic acid:lactosylceramide sialyltransferase; CMP-N-acetylneuraminate:lactosylceramide α-2,6-N-acetylneuraminyltransferase; CMP-N-acetylneuraminate:β-D-galactosyl-(1?4)-β-D-glucosyl(1<->1)ceramide α-(2?6)-N. Enzyme Commission Number: EC 2.4.99.11. CAS No. 55071-95-9. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2695; lactosylceramide α-2,6-N-sialyltransferase; EC 2.4.99.11; 55071-95-9; cytidine monophosphoacetylneuraminate-lactosylceramide sialyltransferase; CMP-acetylneuraminate-lactosylceramide-sialyltransferase; CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase; CMP-sialic acid:lactosylceramide sialyltransferase; CMP-N-acetylneuraminate:lactosylceramide α-2,6-N-acetylneuraminyltransferase; CMP-N-acetylneuraminate:β-D-galactosyl-(1?4)-β-D-glucosyl(1<->1)ceramide α-(2?6)-N-acetylneuraminyltransferase. Cat No: EXWM-2695. | |
| lactosylceramide β-1,3-galactosyltransferase | R may be an oligosaccharide or a glycolipid; lactose can also act as acceptor, but more slowly. Involved in the elongation of oligosaccharide chains, especially in glycolipids. Group: Enzymes. Synonyms: uridine diphosphogalactose-lactosylceramide β1?3-galactosyltransferase; UDP-galactose:D-galactosyl-1,4-β-D-glucosyl-R β-1,3-galactosyltransferase; UDP-galactose:D-galactosyl-(1?4)-β-D-glucosyl-R 3-β-galactosyltransferase; UDP-α-D-galactose:D-galactosyl-(1?4)-β-D-glucosyl-R 3-β-galactosyltransferase. Enzyme Commission Number: EC 2.4.1.179. CAS No. 106769-64-6. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2404; lactosylceramide β-1,3-galactosyltransferase; EC 2.4.1.179; 106769-64-6; uridine diphosphogalactose-lactosylceramide β1?3-galactosyltransferase; UDP-galactose:D-galactosyl-1,4-β-D-glucosyl-R β-1,3-galactosyltransferase; UDP-galactose:D-galactosyl-(1?4)-β-D-glucosyl-R 3-β-galactosyltransferase; UDP-α-D-galactose:D-galactosyl-(1?4)-β-D-glucosyl-R 3-β-galactosyltransferase. Cat No: EXWM-2404. | |
| Lactosyl Ceramide, Bovine | Lactosyl Ceramide neutral glycosphingolipid (GSL) that is the common precursor of the ganglio-, globo-, globoiso-, lacto-, neolacto-, and muco-series of GSL. Promotes a time- and concentration-dependent proliferation of aortic smooth muscle cells via specific activation of ERK 1 (p44 MAP kinase). Also stimulates Ras-GTP loading, MEK and Raf kinases, p44 MAP kinase, and c-fos expression in human aortic smooth muscle cells. Applications: An inducer of ras-gtp loading, mek and raf kinases, p44 map kinase, c-fos expression. Group: Coenzymes. Synonyms: Ceramide β-lactoside. CAS No. 4682-48-8. Purity: ≥98%. Mole weight: 960.4. Form: Solid. Ceramide β-lactoside; Lactosyl Ceramide, Bovine; 4682-48-8. Cat No: COEC-107. | |
| Lactosyl fluoride | Lactosyl fluoride is an extensively employed compound in the realm of biomedical research, exhibiting its remarkable inhibitory potential towards distinct glycosidases and glycosyltransferases that play crucial roles in carbohydrate recognition and processing. This compound serves as an invaluable tool for investigating intricate glycosylation processes and unraveling their profound implications in various ailments, including cancer, diabetes and infectious diseases. Synonyms: alpha-lactosyl fluoride; L-1150; 4-O-|A-D-Galactopyranosyl-|A-D-glucopyranosyl fluoride; (2S,3R,4S,5R,6R)-2-(((2R,3S,4R,5R,6R)-6-Fluoro-4,5-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4S,5R,6R)-2-[(2R,3S,4R,5R,6R)-6-fluoro-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol. CAS No. 7792-96-3. Molecular formula: C12H21FO10. Mole weight: 344.29. | |
| Lactosyl Maprotiline | Lactosyl Maprotiline is the lactose conjugate of Maprotiline, an antidepressant. Molecular formula: C32H43NO10. Mole weight: 601.68. | |
| Lactosyl Maprotiline-d5 | Lactosyl Maprotiline-d5. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C32H38D5NO10, Molecular Weight: 606.72. US Biological Life Sciences. | Worldwide |
| Lactosyl Rasagline | Lactosyl Rasagline. Group: Biochemicals. Alternative Names: (2S, 3R, 4S, 5R, 6R) -2- ( ( (2R, 3S, 4R, 5R, 6R) -6- ( ( (R) -2, 3-Dihydro-1H-inden-1-yl) (prop-2-yn-1-yl) amino) -4, 5-dihydroxy-2- (hydroxymethyl) tetrahydro-2H-pyran-3-yl) oxy) -6- (hydroxymethyl) tetrahydro-2H-pyran-3, 4, 5-triol. Grades: Highly Purified. Pack Sizes: 50mg. US Biological Life Sciences. | Worldwide |
| Lactosyl Rasagline-13C3 | Lactosyl Rasagline-13C3. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C2113C3H33NO10, Molecular Weight: 498.5. US Biological Life Sciences. | Worldwide |
| Lactosylsphingosine | Lactosylsphingosine, a sphingolipid, is a vital biomarker characterizing diverse lysosomal storage disorders such as Niemann-Pick disease and Gaucher disease due to its accumulation within the tissues and blood of affected people. Detection through blood examination or imaging studies makes identification possible. Therapy options include substrate reduction and enzyme replacement therapy. Furthermore, tracking variations in lactosylsphingosine may be employed to monitor therapy response and trace disease advancement, imparting substantial clinical value in disease management. Synonyms: D-lactosyl-beta1-1'-D-erythro-sphingosine; Lactosyl(beta) Sphingosine (d18:1); 2S,3R1-beta-lactosyl-sphing-4-enine; lyso-Lactosylceramide; 1-b-Lactosyl-sphing-4-enine; lyso-LC. Grades: >99%. CAS No. 109785-20-8. Molecular formula: C30H57NO12. Mole weight: 623.77. | |
| Lactotransferrin-H | Lactotransferrin-H is an antibacterial peptide isolated from Homo sapiens. It has activity against gram-positive bacteria, gram-negative bacteria and fungi. Synonyms: Phe-Gln-Trp-Gln-Arg-Asn-Met-Arg-Lys-Val-Arg-Gly-Pro-Pro-Val-Ser. Grades: 98.0%. Molecular formula: C88H140N30O21S. Mole weight: 1986.33. | |
| lactoyl-CoA dehydratase | A bacterial enzyme that is involved in propanoate fermentation (also known as the acrylate pathway). Group: Enzymes. Synonyms: lactoyl coenzyme A dehydratase; lactyl-coenzyme A dehydrase; lactyl CoA dehydratase; acrylyl coenzyme A hydratase; lactoyl-CoA hydro-lyase. Enzyme Commission Number: EC 4.2.1.54. CAS No. 9031-12-3. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5043; lactoyl-CoA dehydratase; EC 4.2.1.54; 9031-12-3; lactoyl coenzyme A dehydratase; lactyl-coenzyme A dehydrase; lactyl CoA dehydratase; acrylyl coenzyme A hydratase; lactoyl-CoA hydro-lyase. Cat No: EXWM-5043. | |
| lactoylglutathione lyase | Also acts on 3-phosphoglycerol-glutathione. Group: Enzymes. Synonyms: methylglyoxalase; aldoketomutase; ketone-aldehyde mutase; glyoxylase I; (R)-S-lactoylglutathione methylglyoxal-lyase (isomerizing). Enzyme Commission Number: EC 4.4.1.5. CAS No. 9033-12-9. Glyoxalase I. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-5339; lactoylglutathione lyase; EC 4.4.1.5; 9033-12-9; methylglyoxalase; aldoketomutase; ketone-aldehyde mutase; glyoxylase I; (R)-S-lactoylglutathione methylglyoxal-lyase (isomerizing). Cat No: EXWM-5339. | |
| Lactulose | Lactulose, a disaccharide composed of galactose and fructose, is a stimulator of health-promoting bacterium growth in the gastrointestinal tract, used to treat chronic constipation and hepatic encephalopathy. Uses: Gastrointestinal agents. Synonyms: 4-O-(b-D-Galactopyranosyl)-D-fructofuranose. Grades: >98%. CAS No. 4618-18-2. Molecular formula: C12H22O11. Mole weight: 342.3. | |
| Lactulose | United States Pharmacopeia (USP) Reference Standard. Group: Pharmacopeia & metrological institutes standardsfood additives, flavours & adulterantsbritish pharmacopoeiaeuropean pharmacopoeia (ph. eur.)pharmacopoeial standards. Alternative Names: Lazet, Vetalakt, MLC 97, Laktusan, Prelax, Farlac, Kristalose, Solactis galactofructose, Normase, Milk Oligosaccharide MLP 95, Well-me, Lactoflex, 4-O-(ß-d-galactopyranosyl)-d-arabino-hex-2-ulofuranose, Lactulose (6CI,7CI), Lactuflor, D-Fructose, 4-O-?-D-galactopyranosyl-, MLS 50, Lactofit, Lael, 4-O-?-D-Galactopyranosyl-D-fructose, Laevilac, Laktulak, D-Lactulose, Bifiteral, Isolactose,Lactulose, Fructose, 4-O-?-D-galactopyranosyl-, D- (8CI), Laevolac, Osmolak, Cephulac, Duphalac, Generlac. | |
| Lactulose | 4-O-b-D-galactopyranosyl D-fructose. non-ionic polyol with sucrose mimetic properties. CAS No. 4618-18-2. Product ID: 3-00216. Molecular formula: C12H22O11. Mole weight: 342.3. Reference: Chem. Commun., 1604, 1992. | |
| Lactulose | Lactulose (4-O-β-D-Galactopyranosyl-D-fructose) is a poorly absorbed sugar that can be used to study constipation and hepatic encephalopathy. The drug generally begins to take effect 8 to 12 hours after administration, but it may take two days to improve constipation. Uses: Scientific research. Group: Natural products. Alternative Names: 4-O-β-D-Galactopyranosyl-D-fructose. CAS No. 4618-18-2. Pack Sizes: 10 mM * 1 mL; 100 mg; 1 g. Product ID: HY-B1172. | |
| Lactulose | 25g Pack Size. Group: Carbohydrates, Sugars. Formula: C12H22O11. CAS No. 4618-18-2. Prepack ID 53854902-25g. Molecular Weight 342.3. See USA prepack pricing. | |
| Lactulose | Pharmaceutical Secondary Standard; Certified Reference Material. Group: Pharmacopeia & metrological institutes standards. | |
| Lactulose-13C | Lactulose-13C. Group: Biochemicals. Alternative Names: 4-O- β-D-Galactopyranosyl-D-fructofuranose-13C; Cephulac-13C; Cholac-13C; Chronulac-13C; Constilac-13C; Constulose-13C; Duphalac-13C; Enulose-13C. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C1113CH22O11, Molecular Weight: 343.29. US Biological Life Sciences. | Worldwide |
| Lactulose impurity 7 | Lactulose impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13360-52-6. Molecular formula: C12H22O11. Mole weight: 342.3. Catalog: APB13360526. | |
| Lactulose impurity 9 | Lactulose impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 113158-51-3. Molecular formula: C18H32O16. Mole weight: 504.44. Catalog: APB113158513. | |
| Lactulose - liquid | Lactulose - liquid is a biomedical product commonly used for developing the stool softener and osmotic laxative. It can also be utilized to decrease serum ammonia levels aiding in studying hepatic encephalopathy disease. Molecular formula: C12H22O11. Mole weight: 342.3. | |
| Lactulose Standard for IC | 1000 mg/L in H2O. Group: Carbohydrate standards. | |
| Lactulose USP | 4-O-b-D-galactopyranosyl D-fructose. useful carbohydrate synthon. Grades: USP. CAS No. 4618-18-2. Product ID: 3-00030. Molecular formula: C12H22O11. Mole weight: 342.3. Purity: USP 52% aqueous concentrate. Reference: Levoglucosenone & Levoglucosans, Z. Witczak, ed., ATL Press, Mt. Prospect, IL, 1994. | |
| Lactupicrin | Lactupicrin (Lactucopicrin) exhibits analgesic, sedative, antimalarial activities and atheroprotective effect. Lactupicrin inhibits acetylcholinesterase (AChE) with an IC 50 of 150.3 μM. Lactupicrin is an orally active characteristic bitter sesquiterpene lactone [1] [2] [3] [4] [5]. Uses: Scientific research. Group: Natural products. Alternative Names: Lactucopicrin. CAS No. 65725-11-3. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg. Product ID: HY-N8290. | |
| Lactyl-CoA | Lactyl-CoA is an acyl-CoA formally condensed from the sulfhydryl group of CoA and the carboxyl group of lactic acid, also known as lactyl-CoA. Lactyl-CoA is essential for the biosynthesis of biodegradable and biocompatible lactic acid-based copolymers[1][2]. Uses: Scientific research. Group: Natural products. CAS No. 1926-57-4. Pack Sizes: 10 mM * 1 mL; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-141540. | |
| Lactyl Phenetidine | Lactyl Phenetidine is used as an inflammation inhibitor. Group: Biochemicals. Alternative Names: N-(4-Ethoxyphenyl)-2-hydroxypropanamide; p-Lactophenetidide; 4'-Ethoxylactanilide; DL-p-Lactophenetidide; Fenolactine; Lactophenin; Lactyl-p-phenetidin; Lactylphenetidin; N-Lactyl-p-phenetidine; NSC 72105; Phenolactine; p-Lactophenetide; p-Lactylphenetidine. Grades: Highly Purified. CAS No. 539-08-2. Pack Sizes: 100mg. US Biological Life Sciences. | Worldwide |
| Lacutamab | Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2 , produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab). CAS No. 2187368-16-5. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99369. | |
| L-a-Cyclohexylglycine | L-a-Cyclohexylglycine. Group: Biochemicals. Grades: Highly Purified. CAS No. 14328-51-9. Pack Sizes: 10g, 25g, 50g, 100g. US Biological Life Sciences. | Worldwide |
| Ladarixin | Ladarixin (DF 2156A free base) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin can be used for the research of COPD and asthma [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DF 2156A free base. CAS No. 849776-05-2. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-19519. | |
| Ladarixin | Ladarixin is Interleukin 8A and Interleukin 8B receptor antagonist. IL-8A and IL-8B inhibition blocks and reverses type 1 diabetes in mice. In Dec 2015, Phase-II clinical trials in Type-1 diabetes mellitus in Italy were on-going. Uses: Type 1 diabetes mellitus. Synonyms: 4-((2R)-1-Oxo-1-(methanesulfonamido)propan-2-yl)phenyl trifluoromethanesulfonate;865625-56-5(sodium). Grades: 98%. CAS No. 849776-05-2. Molecular formula: C11H12F3NO6S2. Mole weight: 375.33. | |
| Ladarixin sodium | Ladarixin sodium (DF 2156A) is an orally active, allosteric non-competitive and dual CXCR1 and CXCR2 antagonist. Ladarixin sodium can be used for the research of COPD and asthma [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: DF 2156A. CAS No. 865625-56-5. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-19519A. | |
| L-Adenosine | L-Adenosine. Group: Biochemicals. Alternative Names: 9-(b-L-Ribofuranosyl)adenine. Grades: Highly Purified. CAS No. 3080-29-3. Pack Sizes: 10mg, 25mg, 50mg. Molecular Formula: C10H13N5O4. US Biological Life Sciences. | Worldwide |
| L-Adenosine 5'-triphosphate sodium salt | L-Adenosine 5'-triphosphate sodium salt, a pivotal biomolecule extensively utilized in the biomedical sector, emerges as a fundamental energy contributor in cellular mechanisms. Its multifaceted involvement encompasses metabolic facilitation, catalyzing enzymatic reactions, and mediating signal transduction pathways. Its indispensability becomes evident when considering its incorporation in pharmaceutical compositions targeting neurological afflictions, cardiac ailments, and maladies attributable to compromised energy metabolism pathways. Molecular formula: C10H12N5O13P3Na4. Mole weight: 595.11. | |
| Ladiratuzumab | Ladiratuzumab (hLIV22) is an anti- LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE (HY-15162) to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer [1] [2]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: hLIV22. CAS No. 1629760-28-6. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99682. | |
| Ladiratuzumab vedotin | Ladiratuzumab vedotin (SGN-LIV1A) is a LIV-1 targeting antibody drug conjugate (ADC) (IC 50 : 5.6 nM for LIV-1). Ladiratuzumab vedotin consists of humanized IgG1 monoclonal antibody, MMAE and a protease-cleavable linker. Ladiratuzumab vedotin can drive immunogenic cell death (ICD) to elicit an immune response. Ladiratuzumab vedotin can be used for research of breast cancer [1] [2] [3] [4]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: SGN-LIV1A. CAS No. 1629760-29-7. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P99683. | |
| Ladostigil | Ladostigil, also called as TV-3,326, is a novel neuroprotective agent developed to treat neurodegenerative disorders sunch as Alzheimer's disease. Ladostigil is a dual acetylcholine-butyrylcholineesterase and brain selective monoamine oxidase (MAO)-A and -B inhibitor in vivo (with little or no MAO inhibitory effect in the liver and small intestine). Synonyms: [(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate; (N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate; Ladostigil; TV 3326; TV3326; TV-3326. Grades: >98%. CAS No. 209394-27-4. Molecular formula: C16H20N2O2. Mole weight: 272.348. | |
| Ladostigil hydrochloride | Ladostigil (TV-3326) hydrochloride is an orally active dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO) , with IC 50 s of 37.1 and 31.8 μM for MAO-B and AChE , respectively. Ladostigil hydrochloride exhibits neuroprotective, antioxidant and anti-inflammatory activities. Ladostigil can be used for the research of depression and Alzheimer's disease [1] [2]. Ladostigil (hydrochloride) is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups. Uses: Scientific research. Group: Signaling pathways. Alternative Names: TV-3326 hydrochloride. CAS No. 209394-18-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-10399A. | |
| Ladostigil tartrate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopy. | |
| Ladostigil tartrate | Ladostigil, also called as TV-3,326, is a novel neuroprotective agent developed to treat neurodegenerative disorders sunch as Alzheimer's disease. Ladostigil is a dual acetylcholine-butyrylcholineesterase and brain selective monoamine oxidase (MAO)-A and -B inhibitor in vivo (with little or no MAO inhibitory effect in the liver and small intestine). Uses: A novel brain-selective mao inhibitor, ladostigil can selectively reverse the behavioral and neurochemical effects induced by prenatal stress without affecting the behavior of controls. antidepressant. Synonyms: ethylmethyl-carbamic acid (3r)-2,3-dihydro-3-(2-propynylamino)-1h-inden-5-yl ester (2r,3r)-2,3-dihydroxybutanedioate (2:1); ladostigil tartrate; Ethylmethyl-carbamic acid (3R)-2,3-dihydro-3-(2-propynylamino)-1H-inden-5-yl ester (2R,3R)-2,3-dihydroxybutaned. Grades: >98%. CAS No. 209394-46-7. Molecular formula: 2(C16H20N2O2).C4H6O6. Mole weight: 694.78. | |
| Ladostigil Tartrate | Multifunctional drug designed to treat Alzhemier?s disease by combining in a single molecule the neuroprotective / neurorestorative effects of the (MAO)-B inhibitor rasagiline with the cholinesterase (ChE) inhibitory activity of rivastigmine. Group: Biochemicals. Alternative Names: N-Ethyl-N-methylcarbamic Acid (3R)-2,3-Dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl Ester (2R,3R)-2,3-Dihydroxybutanedioate; TV 3326. Grades: Highly Purified. CAS No. 209394-46-7. Pack Sizes: 5mg, 25mg. Molecular Formula: C18H23N2O5, Molecular Weight: 347.39. US Biological Life Sciences. | Worldwide |
| L-Adrenaline | L-Adrenaline. Group: Biochemicals. Grades: Highly Purified. CAS No. 51-43-4. Pack Sizes: 5g, 10g, 25g, 50g, 100g. Molecular Formula: C9H13NO3. US Biological Life Sciences. | Worldwide |
| Laduviglusib | Laduviglusib Inhibitor. Uses: Scientific use. Product Category: T2310. CAS No. 252917-06-9. |  |
| Laduviglusib | Laduviglusib (CHIR-99021) is a potent, selective and orally active GSK-3?/? inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib is also a potent Wnt/?-catenin signaling pathway activator. Laduviglusib enhances mouse and human embryonic stem cells self-renewal. Laduviglusib induces autophagy[1][2][3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CHIR-99021; CT99021. CAS No. 252917-06-9. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10182. | |
| Laduviglusib monohydrochloride | Laduviglusib (CHIR-99021) monohydrochloride is a potent and selective GSK-3?/? inhibitor with IC50s of 10 nM and 6.7 nM. Laduviglusib monohydrochloride shows >500-fold selectivity for GSK-3 over CDC2, ERK2 and other protein kinases. Laduviglusib monohydrochloride is also a potent Wnt/?-catenin signaling pathway activator. Laduviglusib monohydrochloride enhances mouse and human embryonic stem cells self-renewal. Laduviglusib monohydrochloride induces autophagy[1][2][3]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: CHIR-99021 monohydrochloride; CT99021 monohydrochloride. CAS No. 1797989-42-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-10182A. | |
Our database is helping our users find suppliers everyday.
